Added to YB: 2024-12-03
Pitch date: 2024-07-02
PAX.ST [bullish]
Paxman AB (publ)
+17.69%
current return
Author Info
No bio for this author
Company Info
Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia.
Market Cap
SEK 1.4B
Pitch Price
SEK 52.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
34.74
P/E
-219.73
EV/Sales
3.56
Sector
Health Care Equipment and Supplies
Category
value
Paxman AB: Transforming Scalability and Growth in Scalp Cooling Solutions
PAX.ST: Market leader in scalp cooling for chemo patients. 5,500+ systems, 60+ markets. US expansion driving growth (36% vs competitor's 9%). New Buy/Bill model boosting utilization 100-300%. Conservative est: 76% margin, 2x sales, 10x 2026e EBIT. Risks: low-tech product, chemo alternatives. CIPN research upside.
Read full article (4 min)